# Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease

> **NCT03317444** · PHASE3 · COMPLETED · sponsor: **Tricida, Inc.** · enrollment: 217 (actual)

## Conditions studied

- Metabolic Acidosis

## Interventions

- **DRUG:** TRC101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03317444
- **Lead sponsor:** Tricida, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-26
- **Primary completion:** 2018-05-04
- **Final completion:** 2018-05-15
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2021-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03317444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03317444, "Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03317444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*